Variant report
Variant | esv16682 |
---|---|
Chromosome Location | chr2:149201747-149202667 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570672307 | chr2:149201760-149201761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1446553 | chr2:149201775-149201776 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs550447575 | chr2:149201818-149201819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs193022168 | chr2:149201836-149201837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112957394 | chr2:149201880-149201881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs67388250 | chr2:149201881-149201882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs5835188 | chr2:149201882-149201883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185214654 | chr2:149201939-149201940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35910260 | chr2:149201944-149201945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554338466 | chr2:149202003-149202004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73019217 | chr2:149202075-149202076 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs140306148 | chr2:149202126-149202127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368992830 | chr2:149202130-149202131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73019220 | chr2:149202176-149202177 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs189720935 | chr2:149202179-149202180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576181874 | chr2:149202181-149202182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543390773 | chr2:149202183-149202184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555619805 | chr2:149202184-149202185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181359952 | chr2:149202192-149202193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541043553 | chr2:149202201-149202202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558889111 | chr2:149202209-149202210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35586888 | chr2:149202230-149202231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183716114 | chr2:149202321-149202322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188431329 | chr2:149202322-149202323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564386907 | chr2:149202337-149202338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531924941 | chr2:149202366-149202367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550243375 | chr2:149202370-149202371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568716441 | chr2:149202420-149202421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529535932 | chr2:149202421-149202422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547830347 | chr2:149202451-149202452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566029992 | chr2:149202454-149202455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114819027 | chr2:149202469-149202470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140952262 | chr2:149202523-149202524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569782766 | chr2:149202552-149202553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372597190 | chr2:149202562-149202563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537227210 | chr2:149202623-149202624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144821730 | chr2:149202629-149202630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs78840900 | chr2:149202641-149202642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540885485 | chr2:149202656-149202657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Glioblastoma | 21080181 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 19904302 | CNVD |
Intellectual disability | 19904302 | CNVD |
Microcephaly | 19904302 | CNVD |
severe speech impairment | 19904302 | CNVD |
Mental retardation | 20152051 | CNVD |
2q23.1 microdeletion syndrome | 18812405 | CNVD |
Mental retardation | 19809484 | CNVD |
Autism | 21981781 | CNVD |
Mental retardation | 17847001 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:149172600-149205000 | Weak transcription | Colon Smooth Muscle | Colon |
2 | chr2:149174200-149221400 | Weak transcription | Primary T cells from cord blood | blood |
3 | chr2:149174400-149221400 | Weak transcription | Primary B cells from cord blood | blood |
4 | chr2:149193000-149226000 | Weak transcription | Primary hematopoietic stem cells | blood |
5 | chr2:149193400-149221600 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
6 | chr2:149194000-149216200 | Weak transcription | Fetal Intestine Small | intestine |
7 | chr2:149194800-149216200 | Weak transcription | Psoas Muscle | Psoas |
8 | chr2:149197000-149202400 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
9 | chr2:149198600-149221600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr2:149198600-149226000 | Weak transcription | HSMM | muscle |
11 | chr2:149202200-149202400 | Enhancers | Right Atrium | heart |